Site icon

Closing the Maternal Mental Health Treatment Gap: A Tech-Enabled Solution

Closing the Maternal Mental Health Treatment Gap - A Tech-Enabled Solution

Image | Google Gemini AI

How automated mental health screening and integrated virtual care are helping health systems achieve 90% improvement rates while improving maternal and infant outcomes.

Suicide and drug overdose now rank among the leading causes of maternal mortality in the United States—a preventable crisis with significant financial consequences for health systems and payers. Perinatal mood and anxiety disorders (PMADs) affect one in five women, yet 50% remain undiagnosed, and 75% of those diagnosed never access treatment. Left untreated, these conditions cost an estimated $14 billion annually through increased healthcare utilization, obstetric complications, NICU admissions, and adverse child development outcomes.

For health plans and hospital systems, the challenge is clear: how do you systematically identify at-risk members, connect them to specialized care quickly, and deliver measurable outcomes? Seven Starling, a specialized virtual perinatal mental health platform, has published its first Patient Outcomes Study from over 6,000 women across 18 states demonstrating this challenge is solvable: 90% of patients showed clinically significant improvement and 62% experienced symptom relief within just two months.

Why Traditional Referral Models Fail

Untreated maternal mental health conditions drive poor outcomes and high costs for health systems. PMADs are linked to preterm birth, low birth weight, preeclampsia, higher ED utilization, extended hospitalizations, and NICU admissions—complications that significantly increase delivery costs while negatively impacting quality metrics and accreditation standards.

Yet the care delivery system remains fragmented. Obstetricians and pediatricians—who see patients regularly during the perinatal period—lack the time, resources, and often the training to manage complex mental health conditions. Traditional mental health referrals face five-week average wait times, geographic provider deserts, high referral leakage, and limited care coordination between obstetric practices and mental health providers.

For payers, this fragmentation translates to missed early intervention opportunities, higher acuity at presentation, and increased total cost of care. Suicide remains a leading cause of death in the first postpartum year, representing preventable sentinel events.

Seven Starling’s Integrated Solution

Seven Starling was purpose-built to solve these systemic failures through three integrated components that work at scale for health systems and payers:

Automated Screening That Drives Systematic Identification

Seven Starling’s digital screening platform automates validated assessments (PHQ-9, GAD-7, Edinburgh Postnatal Depression Scale) within provider workflows, systematically identifying at-risk patients while reducing clinical burden. The platform can be deployed across multiple OB/GYN and pediatric practice sites simultaneously, creating population-level screening across an entire health system or covered population.

Critically, Seven Starling’s data shows 23% of screened patients opt into care even though only 20% screen positive—indicating traditional thresholds miss patients who are symptomatic or at-risk but will engage when offered low-barrier access. Patients screening positive receive immediate prompts to connect with a care coordinator. Those screening negative are enrolled in “Mindful Beginnings,” a preventative program with weekly check-ins that enable escalation if symptoms emerge.

Care Navigation That Eliminates Referral Leakage

Seven Starling’s EMR-integrated referral system enables single-click referrals during routine appointments, eliminating administrative burden. The platform accepts referrals via fax, webform, phone, and embedded screening tools—meeting providers where they are. Over 90% of Seven Starling referrals originate from OB/GYN practices.

Dedicated care coordinators contact patients within 24 hours, achieving over 70% connection rates with most converting to enrollment. Patients are matched with specialized maternal mental health clinicians within one day and seen within seven days on average—compared to the industry standard of five weeks.

This rapid response prevents clinical deterioration. Research shows longer wait times after symptom identification correlate with increased symptom severity. Seven Starling collapses the time between identification and intervention, capturing members during the optimal window before complications arise.

Seven Starling delivers structured progress reports—including treatment status, medications, and validated outcome measures—that integrate directly into patients’ medical records, ensuring referring providers maintain care coordination visibility throughout treatment.

Specialized Virtual Care Delivering Proven Outcomes

Seven Starling’s clinical model includes individual therapy, group therapy, medication management by perinatal psychiatrists, and app-based exercises—all delivered virtually to eliminate transportation and childcare barriers. Clinicians are licensed in multiple states and trained specifically in perinatal mental health, addressing the chronic shortage of perinatal specialists.

The platform currently operates in 18 states with expansion to 30+ states by 2026, with network participation covering over 100 million lives through commercial and Medicaid plans, minimizing member out-of-pocket costs.

Clinical Outcomes That Drive ROI

Seven Starling’s outcomes study demonstrates both clinical efficacy and economic value:

Seven Starling’s patient population includes 37% who identify as BIPOC, with >50% accessing mental health resources for the first time. The platform’s clinical team—over 50% of whom identify as BIPOC—facilitates culturally concordant care that improves engagement among populations with higher maternal morbidity rates. This addresses NCQA health equity accreditation standards and helps close racial disparity gaps impacting Star Ratings and Medicaid quality incentives.

The Business Case for Integration

Health systems and payers evaluating Seven Starling should consider:

Prevention of high-cost complications: Early intervention reduces preterm births, NICU admissions, and obstetric complications driving delivery costs above $50,000 per case.

ED diversion: Rapid access and ongoing care prevent psychiatric crises resulting in expensive emergency utilization.

Quality metrics: Systematic screening and documented outcomes support HEDIS measures for depression screening and follow-up, Star Ratings through preventive care and patient satisfaction, and Medicaid quality incentives.

Scalable implementation: Seven Starling handles provider training, EMR integration, and ongoing support. The automated screening platform deploys across multiple sites simultaneously with minimal IT lift, with most partners live within 30-60 days.

Network adequacy: Virtual delivery extends specialist access to rural and underserved geographies without local provider recruitment.

From Crisis to Solution

The $14 billion annual cost of untreated maternal mental health conditions represents a significant opportunity for health systems and payers implementing proven solutions. Seven Starling has demonstrated that when automated screening is coupled with proactive care navigation and rapid access to specialized virtual care, clinical outcomes improve dramatically.

The infrastructure exists. The outcomes are documented. Seven Starling is operational in 18 states and scaling rapidly. For health systems and payers, the question is not whether solutions exist—it’s how quickly to implement a platform that closes treatment gaps while improving outcomes, reducing costs, and meeting quality benchmarks that matter for accreditation, HEDIS, Star Ratings, and member satisfaction.

Screening saves lives, but only when it connects to care navigation that eliminates leakage and treatment that’s accessible, timely, and effective. Seven Starling delivers all three at scale.

 

About the Author

Dr. Crystal Clark is Director of Clinical Research and a Board-Certified Psychiatrist at Seven Starling, a virtual perinatal mental health platform serving health systems and health plans across 18 states. She is internationally recognized for her expertise in women’s mental health, holds the Canada Research Chair in Reproductive Mental Health, and serves as Associate Professor in the Department of Psychiatry at the University of Toronto. Her research focuses on improving medication management, preventing perinatal illness recurrence, and addressing mental health disparities among populations disproportionately affected by perinatal mood and anxiety disorders.

Exit mobile version